Reply

Ophthalmology. 2016 Feb;123(2):e12-e13. doi: 10.1016/j.ophtha.2015.08.003.

Authors

Raafay Sophie¹, Na Lu², Peter A Campochiaro³

Affiliations

¹ The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.
² Genentech Inc, South San Francisco, California.
³ The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland. Electronic address: pcampo@jhmi.edu.

PMID: 26802714
DOI: 10.1016/j.ophtha.2015.08.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Diabetic Retinopathy / drug therapy*
Female
Fovea Centralis / pathology*
Humans
Macular Edema / drug therapy*
Male
Visual Acuity / physiology*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized